/Companies

Healthtech Startups

18,759 companies tagged Healthtech, with their investors and founders.

MIVI Neuroscience

MIVI develops medical devices to improve outcomes in neurointerventional procedures, specifically targeting aspiration in distal stroke occlusions and reducing distal embolization during mechanical thrombectomy.

0 investors

Mizar Therapeutics

0 investors

MMI Holdings

0 investors

Mobile BAY Lithotripsy

0 investors

Mobile Surgicare

Surgicare of Mobile is an ambulatory surgery center providing ophthalmology, ENT, and gastroenterology services with ten operating rooms and two laser rooms. The facility, established in 1984 and partnered with SCA Health, serves patients and physicians in the Mobile, Alabama area.

0 investors

MobileMedTek Holdings

0 investors

Mobilize RRS

0 investors

Mocean Holdings

0 investors

Mochi Health

0 investors

Model Oncology

0 investors

Modern Clinics

0 investors

Modern Dental Services

0 investors

Modern Medical Holdings

0 investors

Modern Pediatrics

0 investors

Modular Medical

Modular Medical develops the MODD1, an insulin pump designed to simplify the transition from manual daily injections and to enable diabetes data sharing with care teams. It serves people with diabetes and their healthcare providers in the diabetes care market.

0 investors

Molekule Group

0 investors

Momtech

0 investors

Mongoose Bio

Mongoose Bio is a company focused on T-cell therapies for cancer, drawing on research into antigen-specific CD8+ T cells, IL-21 priming, and adoptive cell transfer for tumors such as melanoma and Merkel cell carcinoma.

0 investors

Monj

Monj Health combines culinary expertise with health and nutrition guidance to help people develop cooking skills and make lifestyle choices that support wellbeing. The company is led by a team of chefs, medical professionals, and nutritionists based in California.

0 investors

Monopar Therapeutics

Monopar Therapeutics is a clinical-stage biotechnology company developing radiopharmaceuticals for oncology and a treatment for Wilson Disease, a rare genetic disorder. Its pipeline includes radiopharmaceutical candidates targeting advanced solid tumors (MNPR-101-Zr for imaging, MNPR-101-Lu and MNPR-101-Ac for therapy) and the late-stage Wilson Disease drug ALXN1840.

0 investors

Montrose Physician Investment

0 investors

Moorea Holdings

0 investors

Moose Curve Holdings

0 investors

Morris Innovative

0 investors

Other sectors & tags

Healthtech Startups — Page 707 | Fundraising Fox